Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey

BACKGROUND: In acute lymphoblastic leukemia (ALL), the presence of minimal residual disease (MRD) after induction/consolidation chemotherapy is a strong prognostic factor for subsequent relapse and mortality. Accordingly, European clinical guidelines and protocols recommend testing patients who achi...

詳細記述

保存先:
書誌詳細
出版年:BMC Cancer
主要な著者: Pigneux, Arnaud, Montesinos, Pau, Cong, Ze, Zhang, Xinke, Pownell, Anja K., Wieffer, Heather, McKendrick, Jan, Brüggemann, Monika
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6233570/
https://ncbi.nlm.nih.gov/pubmed/30419861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5002-5
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料